ÄÚ¿À·ÕÁ¦¾à(´ëÇ¥:ÀÌ¿ì¼®)Àº 29ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» È£ÅÚ¿¡¼ Àü±¹ ¾Ë·¹¸£±â·È£Èí±â ³»°ú µî 100¿©¸íÀÌ Âü¼®ÇÑ °¡¿îµ¥ ¼¼°è ÃÖÃÊÀÇ Extra-fine particleÀÇ Ãµ½Äº¹ÇÕÈíÀÔÁ¦ ‘Æ÷½ºÅÍ 100/6 ¿¡ÀÌÄ¡¿¡ÇÁ¿¡ÀÌ’ ·±Äª½ÉÆ÷Áö¾öÀ» ¼ºÈ²¸®¿¡ °³ÃÖÇß´Ù.
À̳¯ ½ÉÆ÷Áö¾ö¿¡¼´Â ¿ï»êÀÇ´ë ¹®Èñ¹ü ±³¼ö(¾Ë·¹¸£±â³»°ú)¿Í °æÈñÀÇ´ë À¯ÁöÈ« ±³¼ö(È£Èí±â³»°ú)°¡ °øµ¿ ÁÂÀåÀ» ¸ÃÀº °¡¿îµ¥ Prof. Leonardo M. Fabbri(the University of Modena and Reggio Emilia, Italy)°¡ ‘New approaches to the treatment of asthma’, Dr. Andrea Bizzi(Chiesi Farmaceutici, Italy)°¡ ‘Development background & clinical benefits of Foster’¿¡ ´ëÇÑ ÁÖÁ¦·Î °¢°¢ ¹ßÇ¥Çß´Ù.
¿¡ÀÌÄ¡¿¡ÇÁ¿¡ÀÌ´Â ½Å±â¼úÀÎ Modulite® technology¸¦ µµÀÔÇÑ ¼¼°è ÃÖÃÊÀÇ Extra-fine particle·Î½á ¼Ò±âµµ¸¦ Æ÷ÇÔÇØ 31%ÀÇ ³ôÀº ÆóħÂøÀ²À» ³ªÅ¸³½´Ù. ±× °á°ú, ¼Ò±âµµ¿¡¼ÀÇ ¿°Áõ±îÁö ¾ïÁ¦Çϱ⠶§¹®¿¡, Æó ÀüüÀÇ ¿°ÁõÀ» È¿°úÀûÀ¸·Î Á¶ÀýÇÏ´Â »õ·Î¿î Â÷¿øÀÇ Ãµ½ÄÄ¡·áÁ¦ÀÌ´Ù. ÄÚ¿À·ÕÁ¦¾à ¸¶ÄÉÆ÷¿µ¾÷º»ºÎ¸¦ ¸Ã°í ÀÖ´Â ÃÖÇü½Ä Àü¹«´Â Æ÷½ºÅ͸¦ ÅëÇØ Ãµ½Ä ½ÃÀå¿¡ »õ·Ó°Ô ÁøÀÔÇØ ÇâÈÄ 2011³â±îÁö 100¾ï´ëÀÇ ºí·Ï¹ö½ºÅÍ Ç°¸ñÀ¸·Î ¼ºÀå½Ãų °èȹÀ̶ó°í ¹àÇû´Ù.